CCL21‐Ser expression in melanoma cells recruits CCR7 + naïve T cells to tumor tissues and promotes tumor growth
Cancer Science · 2023
DOI: 10.1111/cas.15902 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2023. Verfasst von Megumi Miyamoto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Science, Graduate School of Science and Engineering, Kindai University, Osaka, Japan. Hauptthemen laut MEDLINE: T-Lymphocytes, Melanoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
CCL21‐Ser, a chemokine encoded by the Ccl21a gene, is constitutively expressed in the thymic epithelial cells and stromal cells of secondary lymphoid organs. It regulates immune cell migration and survival through its receptor CCR7. Herein, using CCL21‐Ser‐expressing melanoma cells and the Ccl21a ‐deficient mice, we demonstrated the functional role of cancer cell‐derived CCL21‐Ser in melanoma growth in vivo. The B16‐F10 tumor growth was significantly decreased in Ccl21a ‐deficient mice compared with that in wild‐type mice, indicating that host‐derived CCL21‐Ser contributes to melanoma proliferation in vivo. In Ccl21a ‐deficient mice, tumor growth of melanoma cells expressing CCL21‐Ser was significantly enhanced, suggesting that CCL21‐Ser from melanoma cells promotes tumor growth in the absence of host‐derived CCL21‐Ser. The increase in tumor growth was associated with an increase in the CCR7 + CD62L + T cell frequency in the tumor tissue but was inversely correlated with Treg frequency, suggesting that naïve T cells primarily promote tumor growth. Adoptive transfer experiments demonstrated that naïve T cells are preferentially recruited from the blood into tumors with melanoma cell‐derived CCL21‐Ser expression. These results suggest that CCL21‐Ser from melanoma cells promotes the infiltration of CCR7 + naïve T cells into the tumor tissues and creates a tumor microenvironment favorable for melanoma growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Science, Graduate School of Science and Engineering, Kindai University, Osaka, Japan.
- Faculty of Science and Engineering, Kindai University, Osaka, Japan.
- Division of Experimental Immunology, Institute of Advanced Medical Sciences, University of Tokushima, Tokushima, Japan.
- Research Institute for Science and Technology, Kindai University, Osaka, Japan.
ORCID-Profile: Haruko Hayasaka
Zitieren
APA
Miyamoto, M., Kawato, Y., Fujie, R., Kurowarabe, K., Fujiwara, K., Nobusawa, R., Hayashi, R., Iida, K., Ohigashi, I., & Hayasaka, H. (2023). CCL21‐Ser expression in melanoma cells recruits CCR7 + naïve T cells to tumor tissues and promotes tumor growth. Cancer Science. https://doi.org/10.1111/cas.15902
Vancouver
Miyamoto M, Kawato Y, Fujie R, Kurowarabe K, Fujiwara K, Nobusawa R, et al. CCL21‐Ser expression in melanoma cells recruits CCR7 + naïve T cells to tumor tissues and promotes tumor growth. Cancer Science. 2023. doi:10.1111/cas.15902
BibTeX
@article{Miyamoto2023,
author = {Miyamoto, Megumi and Kawato, Yuki and Fujie, Ryonosuke and Kurowarabe, Kaoru and Fujiwara, Kakeru and Nobusawa, Reika and Hayashi, Ryota and Iida, Kei and Ohigashi, Izumi and Hayasaka, Haruko},
title = {CCL21‐Ser expression in melanoma cells recruits CCR7 + naïve T cells to tumor tissues and promotes tumor growth},
journal = {Cancer Science},
year = {2023},
doi = {10.1111/cas.15902}
}
EUVIMED